These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19461661)

  • 1. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008.
    Michino M; Abola E; ; Brooks CL; Dixon JS; Moult J; Stevens RC
    Nat Rev Drug Discov; 2009 Jun; 8(6):455-63. PubMed ID: 19461661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
    Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
    Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand modulation of sidechain dynamics in a wild-type human GPCR.
    Clark LD; Dikiy I; Chapman K; Rödström KE; Aramini J; LeVine MV; Khelashvili G; Rasmussen SG; Gardner KH; Rosenbaum DM
    Elife; 2017 Oct; 6():. PubMed ID: 28984574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.
    Massink A; Holzheimer M; Hölscher A; Louvel J; Guo D; Spijksma G; Hankemeier T; IJzerman AP
    Purinergic Signal; 2015 Dec; 11(4):581-94. PubMed ID: 26482925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicted 3D structures for adenosine receptors bound to ligands: comparison to the crystal structure.
    Goddard WA; Kim SK; Li Y; Trzaskowski B; Griffith AR; Abrol R
    J Struct Biol; 2010 Apr; 170(1):10-20. PubMed ID: 20079848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
    Jaakola VP; Griffith MT; Hanson MA; Cherezov V; Chien EY; Lane JR; Ijzerman AP; Stevens RC
    Science; 2008 Nov; 322(5905):1211-7. PubMed ID: 18832607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A
    Rucktooa P; Cheng RKY; Segala E; Geng T; Errey JC; Brown GA; Cooke RM; Marshall FH; Doré AS
    Sci Rep; 2018 Jan; 8(1):41. PubMed ID: 29311713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features of adenosine receptors: from crystal to function.
    Piirainen H; Ashok Y; Nanekar RT; Jaakola VP
    Biochim Biophys Acta; 2011 May; 1808(5):1233-44. PubMed ID: 20595055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of an agonist-bound human A2A adenosine receptor.
    Xu F; Wu H; Katritch V; Han GW; Jacobson KA; Gao ZG; Cherezov V; Stevens RC
    Science; 2011 Apr; 332(6027):322-7. PubMed ID: 21393508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment.
    Loo JSE; Emtage AL; Ng KW; Yong ASJ; Doughty SW
    J Mol Graph Model; 2018 Mar; 80():38-47. PubMed ID: 29306746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond rhodopsin: G protein-coupled receptor structure and modeling incorporating the beta2-adrenergic and adenosine A(2A) crystal structures.
    Tebben AJ; Schnur DM
    Methods Mol Biol; 2011; 672():359-86. PubMed ID: 20838977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.
    Segala E; Guo D; Cheng RK; Bortolato A; Deflorian F; Doré AS; Errey JC; Heitman LH; IJzerman AP; Marshall FH; Cooke RM
    J Med Chem; 2016 Jul; 59(13):6470-9. PubMed ID: 27312113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
    Beuming T; Sherman W
    J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
    Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
    Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity.
    Moro S; Deflorian F; Bacilieri M; Spalluto G
    Curr Pharm Des; 2006; 12(17):2175-85. PubMed ID: 16796562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells.
    Stoddart LA; Kindon ND; Otun O; Harwood CR; Patera F; Veprintsev DB; Woolard J; Briddon SJ; Franks HA; Hill SJ; Kellam B
    Commun Biol; 2020 Nov; 3(1):722. PubMed ID: 33247190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for allosteric regulation of GPCRs by sodium ions.
    Liu W; Chun E; Thompson AA; Chubukov P; Xu F; Katritch V; Han GW; Roth CB; Heitman LH; IJzerman AP; Cherezov V; Stevens RC
    Science; 2012 Jul; 337(6091):232-6. PubMed ID: 22798613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.